December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Shushan Hovsepyan: Must-Attend Educational Sessions at ESMO 2024
Aug 15, 2024, 16:57

Shushan Hovsepyan: Must-Attend Educational Sessions at ESMO 2024

Shushan Hovsepyan shared on LinkedIn:

“Must-Attend Educational Sessions at ESMO 2024.

Get ready for ESMO 2024 with my list of not-to-miss educational sessions:

Oncofertility: What every HCP involved in cancer care should know?

  • Gonadal toxicities, fertility preservation for female and male patients
    Matteo Lambertini, C. Wyns, Isabelle Demeestere, C. Bergerot

The dark age of single cancer screening is over.

  • Pan-cancer screening test, integrated prevention centers.
    Dario Trapani, Nadir Arber, Robert Benamouzig, Charles Swanton

ESMO – European Society for Medical Oncology and World Health Organization Tackling cancer worldwide.

  • Global cancer control, Universal Health Coverage, WHO initiatives
    Bente Mikkelsen, A. Ilbavi, Jose Martin-Moreno

Can pragmatic clinical trials and optimisation of treatments support development, access and value?

  • European Medicines Agency forum, trial design, WHO medicine platform
    B. Wieseler, Denis Lacombe, Francesco Pignatti, Daniel Goldstein, Sarah Garner

Rare Cancers

  • European Union Cancer Mission, what’s missing from physician and patient perspectives.
    Winette van der Graaf, Jeliazko Arabadjiev, Katie Rizv

ESMO – European Society for Medical Oncology- IARC – International Agency for Research on Cancer / World Health Organization- Medical oncology and cancer prevention: The odd couple?

  • Oncologists’ role in prevention, IARC resources in practice.
    Elisabete Weiderpass, Nadir Arber, Josep Tabernero 

Protein degradation as a novel approach for cancer therapy.

  •  Pharmacological aspects, designing degraders, clinical progress
    Sophie Postel-Vinay, Alex Adjei, Jordi Rodón, Zoran Rankovic

Differential diagnosis and management of clinical syndromes.

  • Carcinoid syndrome, NETs, paraganglioma and pheochromocytoma
    Rachel Riechelmann, R. Garcia-Carbonero, Gregory Kaltsas, Ashley Grossman, Simona Glasberg.”

Shushan Hovsepyan

Source: Shushan Hovsepyan/LinkedIn

Shushan Hovsepyan is a pediatric oncologist and adjunct assistant professor at the Yerevan State Medical University. Currently, she is the Editor-in-Chief of OncoDaily Medical Journal.

She completed her clinical fellowship at the National Institute of Cancer in Milan, Italy and at the St. Anna Children’s Research Hospital in Austria Furthermore, she held a research fellowship position at the European Organisation for Research and Treatment of Cancer in Brussels, Belgium.

She is a former co-chair of the SIOP Global Health Network Education and Training Working Group.